Werner Kroll
Chief Tech/Sci/R&D Officer chez QUIDELORTHO CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Werner Kroll est vice-président senior chargé de la recherche et du développement chez Quidel Corp. Le Dr. Kroll est également membre du conseil d'administration de l'European Personalised Medicine Association. Auparavant, le Dr Kroll était vice-président et directeur de la recherche et de l'innovation chez Novartis Institutes for Biomedical Research, Inc. Le Dr Kroll a obtenu un doctorat de l'université Philipps de Marbourg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
QUIDELORTHO CORPORATION
0,05% | 28/03/2024 | 35 781 ( 0,05% ) | 2 M $ | 31/03/2024 |
Postes actifs de Werner Kroll
| Sociétés | Poste | Début |
|---|---|---|
| QUIDELORTHO CORPORATION | Chief Tech/Sci/R&D Officer | - |
| European Personalised Medicine Association | Director/Board Member | - |
Anciens postes connus de Werner Kroll
| Sociétés | Poste | Fin |
|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Werner Kroll
| Philipps University of Marburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUIDELORTHO CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| European Personalised Medicine Association |
